[{"name":"Episode 1","headline":"Immune Checkpoint Inhibitors have been transformative for cancer care. What have we learnt so far?\nHosts: \nDr. Afreen Shariff, MD, Endocrinologist, Duke Cancer Institute; \nDr. Tian Zhang, MD, MHS, Genito-Urinary Oncologist, Duke Cancer Institute","link_spotify":"http://www.freebsddiary.org/APC/usb_hid_usages.php","link_apple":"http://www.freebsddiary.org/APC/usb_hid_usages.php"},{"name":"Episode 2","headline":"Top 10 tips from an Endocrine toxicity expert on managing Immune related Thyroid dysfunction. \nHosts:\nDr. Afreen Shariff, MD\nDr. Tian Zhang, MD, MHS","link_spotify":"https://www.netlifycms.org/","link_apple":"https://www.netlifycms.org/"}]